NTRA

#442
Natera, Inc. Common Stock
213.54 USD
+5.77%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
206.36
215.00
Rango anual
131.81
256.27
Cambio diario
+5.77%
Variación mensual
+11.54%
Variación en los últimos 6 meses
+23.26%
Cambio anual
+43.42%
Cierres anteriores
201.90
Abrir
207.81
Bid
Ask
Mínimo
206.36
High
215.00
Volumen
166
Ver el calendario completo

Financials

Visión general Informes Estadísticas
Trimestre Año
  • Market Capitalization 30.27 B
  • Employee 6 140
  • Founded 2004
  • CEO Steven Chapman
  • Website www.natera.com
  • Headquarter Delaware, United States
  • FIGI BBG001J1BQ86
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-150.72
Relación precio/flujo de caja
13.58

Natera Inc

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA testing technology, with a focus on women's health, cancer, and organ health. Natera's proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments in San Carlos, California and Austin, Texas.

Noticias